Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 0121)

Hiroshima 730-8619

0 studies enrolling now · 1 studies all time

What they study most

Cytomegalovirus Infection

Studies at this site

• Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040) — Completed